Pulmonary Arterial Hypertension in Patients with Primary Sjögren’s Syndrome

Table 2

Comparison of demographic and clinical features in pSS patients with and without pulmonary artery hypertension.

	pSS with PAH (𝑁=11, 23.4%)	pSS without PAH (𝑁=36, 76.6%)	𝑃 value
Age (mean)	41.6	59.2	0.04
Duration of disease (years)	4.3	9.5	0.04
Dry eyes	10 (90.9%)	29 (80.6%)	0.424
Dry mouth	9 (23.1%)	30 (76.9%)	0.907
Arthralgia	9 (81.8%)	33 (91.7%)	0.354
CNS involvement	1 (9.1%)	0 (0%)	0.675
Raynaud’s phenomenon	1 (9.1%)	7 (19.4%)	0.424
Anti-Ro Ab	7 (63.6%)	21 (58.3%)	0.754
Anti-La Ab	4 (36.4%)	16 (44.4%)	0.635
C-reactive protein	3 (27.3%)	8 (22.2%)	0.729
ESR	5 (45.5%)	13 (36.1%)	0.577